Quotient Clinical, the Translational Pharmaceutics® company, a leading provider of early stage and specialist drug development services, today announced the expansion of its Data Sciences function with relocation to a larger office, staying in Edinburgh.

The expansion comes in response to growing customer demand for the Data Sciences service. The total Data Sciences headcount has increased by more than 34% during the past two years and is now at over 50 employees. Quotient Clinical is currently actively recruiting.

Quotient Clinical’s Data Sciences offering supports its proprietary Translational Pharmaceutics platform, which integrates formulation development, real-time adaptive GMP manufacturing and clinical testing. The Data Sciences experts provide bespoke services for early phase clinical studies including: data management, eCRF programming, statistics and statistical programming, pharmacokinetic modelling and simulation, and medical writing. These capabilities deliver real-time data to customers for review and interpretation, enabling crucial dosing decisions to be made during the course of a study and to aid development of clinical programs post study.

Greg Johnson, VP Data Sciences, Quotient Clinical, commented: “Our unique Translational Pharmaceutics platform is increasingly being recognised in the industry for reducing clinical development timelines, cutting associated costs, and offering enhanced data-based decision making ability throughout the process. As a consequence, demand for our integrated Data Sciences service is also growing, and we are therefore delighted to announce this expansion and the move to a new larger office, ensuring that customers continue to receive the highest standard of service.”

Translational Pharmaceutics brings innovation to early drug development by integrating formulation development, real-time adaptive GMP manufacturing and clinical testing within a single organisation. Drug products are manufactured in real-time immediately prior to clinical testing, creating the opportunity to modify dose and formulation compositions in response to emerging clinical data (safety, pharmacokinetic or pharmacodynamic). The platform can be applied to a wide range of drug products, including oral, inhaled, dermal and IV, and encompasses simple and complex formulation types.

To find out more about Quotient Clinical, please go to the website.

Latest Opportunities

Calling Supply Chain Innovators: Grants of £100,000 Available!

Funding call for supply chain innovators for grants of up to £100,000 As a Research…

Medical devices regulations: targeted consultation on the indefinite recognition of CE marked devices

Summary This consultation invites views on proposals for recognising CE marked medical devices in Great Britain.…

Mental Health First Aid training offer for the Medilink Midlands network

What Red Umbrella offer With tailored delivery and expert integration, every Red Umbrella engagement is…

Latest News

Anglia Ruskin University - Patron Spotlight

Medilink Midlands offers Patronage to leading organisations that champion the medtech and life sciences sector. …

HORIBA to Build a New Global Headquarters

Advancing global operations and realigning domestic sites to strengthen the organisation and lay the groundwork…

MHRA launches a consultation on indefinite recognition of CE-marked medical devices

The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched a consultation on proposals for indefinite recognition…

Your innovation deserves recognition

The Medilink Midlands Awards are now open, celebrating outstanding innovation across the region’s medtech and life sciences sector.

With 10 categories to enter, now’s the time to showcase your achievements.
Extended Deadline Date: 16th January

Start your application today.

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​